Inotiv share price today

(NOTV)

Inotiv share price is $5.4 & ₹463.37 as on 7 Jan 2025, 2.30 'hrs' IST

$5.4

▲

0.37

(7.36%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Inotiv share price in Dollar and Rupees. Guide to invest in Inotiv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Inotiv, along with analyst recommendations, forecasts, and comprehensive financials.

Inotiv share price movements

Today's Low: $5.03
Today's High: $5.67
$5.40
6.85%
Downside
Day's Volatility :11.29%
Upside
4.76%
52 Weeks Low: $1.23
52 Weeks High: $11.42
$5.40
77.28%
Downside
52 Weeks Volatility :89.25%
Upside
52.7%

Inotiv Returns

Period	Inotiv Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	173.37%	-8.4%	0.0%
6 Months	182.58%	-3.8%	0.0%
1 Year	22.09%	-0.1%	0.0%
3 Years	-85.43%	2.9%	-19.8%

Inotiv Key Statistics

in dollars & INR

Previous Close	$5.03
Open	$5.18
Today's High	$5.67
Today's Low	$5.03
Market Capitalization	$132.5M
Today's Volume	$1.0M
52 Week High	$11.4166
52 Week Low	$1.227
Revenue TTM	$501.1M
EBITDA	$19.0M
Earnings Per Share (EPS)	$-4.19
Profit Margin	-19.8%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-43.15%

How to invest in Inotiv from India?

It is very easy for Indian residents to invest directly in Inotiv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inotiv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inotiv or NOTV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inotiv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inotiv shares which would translate to 0.159 fractional shares of Inotiv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inotiv, in just a few clicks!

Returns in Inotiv for Indian investors in Rupees

Investment Value

₹1,00,000

Inotiv investment value today

Current value as on today

₹1,34,291

Returns

₹34,291

(+34.29%)

Returns from Inotiv Stock

₹31,068 (+31.07%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Inotiv

-45%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Inotiv on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -45% less investors are searching Inotiv in the last 30 days versus the previous period.

Global Institutional Holdings in Inotiv

Vanguard Group Inc
4.05%
Ameriprise Financial Inc
1.03%
Geode Capital Management, LLC
0.96%
Kpp Advisory Services LLC
0.91%
BlackRock Inc
0.82%
D. E. Shaw & Co LP
0.72%

Analyst Recommendation on Inotiv

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Inotiv(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Inotiv

What analysts predicted

Upside of 23.46%

Current:

$5.40

Target:

$6.67

Insights on Inotiv

Price Movement
In the last 7 days, NOTV stock has moved up by 19.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 105.78M → 130.41M (in $), with an average increase of 18.9% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -48.07M → -18.89M (in $), with an average increase of 61.2% per quarter
NOTV vs A (3 yr)
In the last 3 years, Inotiv Inc has experienced a drawdown of -85.7%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 76.7%

Inotiv Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$43.6M	↑ 65.55%
Net Income	$-790.0K	↑ 307.22%
Net Profit Margin	-1.81%	↓ 1.07%

	FY20	Y/Y Change
Revenue	$60.5M	↑ 38.64%
Net Income	$-4.7M	↑ 493.04%
Net Profit Margin	-7.75%	↓ 5.94%

	FY21	Y/Y Change
Revenue	$89.6M	↑ 48.18%
Net Income	$10.9M	↓ 332.55%
Net Profit Margin	12.16%	↑ 19.91%

	FY22	Y/Y Change
Revenue	$547.7M	↑ 511.19%
Net Income	$-337.3M	↓ 3195.57%
Net Profit Margin	-61.58%	↓ 73.74%

	FY23	Y/Y Change
Revenue	$572.4M	↑ 4.52%
Net Income	$-105.1M	↓ 68.83%
Net Profit Margin	-18.37%	↑ 43.21%

	FY24	Y/Y Change
Revenue	$490.7M	↓ 14.27%
Net Income	$-108.4M	↑ 3.14%
Net Profit Margin	-22.1%	↓ 3.73%

	Q2 FY23	Q/Q Change
Revenue	$157.5M	↑ 3.96%
Net Income	$1.8M	↓ 119.11%
Net Profit Margin	1.17%	↑ 7.53%

	Q3 FY23	Q/Q Change
Revenue	$140.7M	↓ 10.62%
Net Income	$-9.7M	↓ 625.16%
Net Profit Margin	-6.87%	↓ 8.04%

	Q4 FY23	Q/Q Change
Revenue	$135.5M	↓ 3.72%
Net Income	$-15.4M	↑ 59.25%
Net Profit Margin	-11.36%	↓ 4.49%

	Q1 FY24	Q/Q Change
Revenue	$119.0M	↓ 12.15%
Net Income	$-48.1M	↑ 212.44%
Net Profit Margin	-40.39%	↓ 29.03%

	Q2 FY24	Q/Q Change
Revenue	$105.8M	↓ 11.13%
Net Income	$-26.1M	↓ 45.74%
Net Profit Margin	-24.66%	↑ 15.73%

	Q3 FY24	Q/Q Change
Revenue	$130.4M	↑ 23.28%
Net Income	$-18.9M	↓ 27.58%
Net Profit Margin	-14.49%	↑ 10.17%

	FY19	Y/Y Change
Profit	$12.9M	↑ 59.2%

	FY20	Y/Y Change
Profit	$18.2M	↑ 41.14%

	FY21	Y/Y Change
Profit	$30.2M	↑ 65.36%

	FY22	Y/Y Change
Profit	$157.2M	↑ 421.33%

	FY23	Y/Y Change
Profit	$165.4M	↑ 5.24%

	FY24	Y/Y Change
Profit	$111.2M	↓ 32.8%

	Q2 FY23	Q/Q Change
Profit	$55.1M	↑ 22.68%

	Q3 FY23	Q/Q Change
Profit	$43.7M	↓ 20.72%

	Q4 FY23	Q/Q Change
Profit	$19.2M	↓ 56.01%

	Q1 FY24	Q/Q Change
Profit	$12.5M	↓ 34.85%

	Q2 FY24	Q/Q Change
Profit	$21.1M	↑ 68.34%

	Q3 FY24	Q/Q Change
Profit	$29.9M	↑ 42.02%

	FY19	Y/Y Change
Operating Cash Flow	$1.8M	↓ 49.04%
Investing Cash Flow	$-8.1M	↑ 0.93%
Financing Cash Flow	$6.2M	↑ 25.96%

	FY20	Y/Y Change
Operating Cash Flow	$1.3M	↓ 27.41%
Investing Cash Flow	$-10.1M	↑ 24.32%
Financing Cash Flow	$9.6M	↑ 55.37%

	FY21	Y/Y Change
Operating Cash Flow	$10.7M	↑ 733.02%
Investing Cash Flow	$-54.1M	↑ 433.61%
Financing Cash Flow	$198.8M	↑ 1962.36%

	FY22	Y/Y Change
Operating Cash Flow	$-5.2M	↓ 148.55%
Investing Cash Flow	$-333.7M	↑ 517.32%
Financing Cash Flow	$203.2M	↑ 2.17%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$3.7M	↓ 71.22%
Investing Cash Flow	$-4.5M	↓ 46.56%
Financing Cash Flow	$-1.0M	↓ 10.17%

Inotiv Technicals Summary

Sell

Neutral

Buy

Inotiv is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Inotiv Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inotiv Inc	28.32%	182.58%	22.09%	-85.43%	-70.36%
Idexx Laboratories, Inc.	-7.8%	-13.05%	-23.61%	-25.62%	49.5%
Agilent Technologies Inc.	-5.77%	8.19%	1.73%	-6.52%	55.48%
Thermo Fisher Scientific, Inc.	-0.97%	0.03%	-1.73%	-14.88%	61.41%
Danaher Corp.	-0.45%	-2.06%	-0.01%	-22.5%	48.94%
Iqvia Holdings Inc.	-4.38%	-7.35%	-11.9%	-23.26%	23.76%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inotiv Inc	NA	NA	NA	-0.75	-0.43	-0.03	NA	7.0
Idexx Laboratories, Inc.	39.83	39.83	4.35	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.63	30.63	2.26	5.56	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.58	32.58	1.98	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	43.31	43.31	3.07	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	25.94	25.94	1.03	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inotiv Inc	Buy	$132.5M	-70.36%	NA	-19.8%
Idexx Laboratories, Inc.	Buy	$33.9B	49.5%	39.83	22.53%
Agilent Technologies Inc.	Buy	$38.8B	55.48%	30.63	21.75%
Thermo Fisher Scientific, Inc.	Buy	$199.0B	61.41%	32.58	14.48%
Danaher Corp.	Buy	$165.8B	48.94%	43.31	16.39%
Iqvia Holdings Inc.	Buy	$35.8B	23.76%	25.94	9.17%

About Inotiv

*we are a cro and lab instrumentation provider* basi is a drug discovery and development services company with the energy and expertise to help you with your drug development project. we provide world-class research to the global pharmaceutical industry. our services include preclinical toxicology, early in vivo pk, bioanalysis and a full range of pharmaceutical analysis services. basi also manufactures innovative scientific instruments including the culex® automated in vivo sampling system which can collect blood, bile, microdialysates, activity behavior, telemetry data and more from awake, freely-moving subjects. we are known for our scientific expertise, responsiveness to clients, exemplary regulatory record, and helping our clients meet key milestones on time.

Organization	Inotiv
Employees	1955
CEO	Mr. Robert W. Leasure Jr.
Industry	Healthcare

Management People of Inotiv

Name	Title
Mr. Robert W. Leasure Jr.	President, CEO & Director
Ms. Beth A. Taylor CPA	Senior VP of Finance & CFO
Dr. John E. Sagartz D.V.M., DiplomateACVP, Ph.D.	Chief Strategy Officer & Director
Dr. Peter T. Kissinger	Founder, Chairman Emeritus & Scientific Advisor
Mr. Brennan Freeman	VP of Finance, Principal Accounting Officer & Corporate Controller
Ms. Andrea Castetter	SVP of General Counsel, Corporate Secretary & Chief Compliance Officer
Mr. Jeffrey Arthur Krupp	Chief Human Resources Officer
Mr. John Gregory Beattie DSA	Chief Operating Officer of DSA
Dr. Adrian Hardy Ph.D.	Chief Commercial Officer
Ms. Lizanne Muller	Group President of RMS

Important FAQs about investing in Inotiv from India :

What is Inotiv share price today?

Inotiv share price today stands at $5.40, Open: $5.18 ; Previous Close: $5.03 ; High: $5.67 ; Low: $5.03 ; 52 Week High: $11.42 ; 52 Week Low: $1.23. The stock opens at $5.18, after a previous close of $5.03. The stock reached a daily high of $5.67 and a low of $5.03, with a 52-week high of $11.42 and a 52-week low of $1.23.

Can Indians buy Inotiv shares?

Yes, Indians can invest in the Inotiv (NOTV) from India.

With INDmoney, you can buy Inotiv at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Inotiv at zero transaction cost.

How can I buy Inotiv shares from India?

It is very easy to buy Inotiv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inotiv be purchased?

Yes, you can buy fractional shares of Inotiv with INDmoney app.

What are the documents required to start investing in Inotiv stocks?

To start investing in Inotiv, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.